Mukesh Ambani donates ₹151 crore to alma mater ICT
MUMBAI: Industrialist Mukesh Ambani on Friday announced an unconditional grant of ₹151 crore to his alma mater, the Institute of Chemical Technology (ICT, formerly UDCT), Mumbai. The donation was made in honour of Prof M M Sharma, on the occasion of the release of his biography Divine Scientist, published in both Marathi and English.
Ambani shared personal memories of Prof Sharma, recalling how the first lecture he attended by him shaped his path. 'Like my father Dhirubhai Ambani, he had a burning desire to change Indian industry from scarcity to global leadership,' said Ambani. 'These two bold visionaries believed that science and technology, in alliance with private entrepreneurship, would open the floodgates of prosperity.'
Crediting the rise of the Indian chemical industry to Prof Sharma's efforts, Ambani called him a 'Rashtra Guru' and 'a Guru of Bharat.' Ambani said the ₹151 crore unconditional donation was his guru dakshina made as per Prof Sharma's instruction. 'When he tells us something, we just listen. We don't think,' Ambani said.
The event was held at ICT's Pidilite Hall and presided over by senior nuclear scientist Anil Kakodkar. Several eminent scientists, including Raghunath Mashelkar, J B Joshi, Aniruddha Pandit, and G D Yadav, paid tribute to Prof Sharma's legacy in education and science.
Divine Scientist was written in Marathi by Anita Patil and translated into English by Sonia Khare.
Prof Sharma, who joined UDCT as a professor at 27, has dedicated over six decades to teaching and research. His former students, many of whom went on to become pioneers in Indian science, recalled his influence and humility.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
11 minutes ago
- Time of India
What is RSV and why are infants especially at risk in India?
Respiratory Syncytial Virus, commonly known as RSV, is the leading cause of respiratory illness in children and infants worldwide. In India, RSV has also become a major issue for parents as well as pediatricians, particularly in the post-monsoon and winter seasons when cases surge. Although the nation continues to establish complete surveillance information, existing studies in tertiary care facilities show that RSV contributes 30% to 50% of bronchiolitis and pneumonia incidents in children aged two years and below. RSV is usually responsible for the symptoms of a cold in older children and adults. Nevertheless, in infants—especially those under six months of age, those who were premature at birth, or those with underlying health issues—the virus may cause severe lower respiratory tract infections, including bronchiolitis (inflammation of small airways) and pneumonia. These two diseases usually require hospitalization, and hospitalization rates between 3 and 5 per 100 infants less than one year of age per year have been estimated in India. The risks are not equal throughout the nation. Geographic and socioeconomic variations account for both the risk of and outcome of RSV infection. Children living in lower-income populations or in densely populated urban environments can have increased exposure from lesser access to healthcare, suboptimal ventilation, and slower diagnosis. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Eat 1 Teaspoon Every Night, See What Happens A Week Later [Video] getfittoday Undo Seeing the international burden of RSV, the World Health Organization (WHO) recently supported maternal RSV vaccination as a prevention approach. This entails immunizing pregnant women so that antibodies are passed on to the unborn child, providing immunity in the vulnerable early months of life. Although not yet included in India's Universal Immunization Programme (UIP), Indian health authorities, such as the Indian Academy of Pediatrics, are in the process of evaluating the vaccine's safety, effectiveness, and affordability in India. Phased introduction in high-risk groups could be the initial step. Apart from vaccines, monoclonal antibodies too have been promising in the prevention of RSV-related complications. These provide passive immunity in a single dose of injection. But the big constraint is cost. Without government incentives or being covered under public health schemes, these therapies could prove to be out of reach for the majority of Indian families. Differential pricing models and collaborations with insurance companies will become paramount in order to expand access. More encouragingly, Indian drug makers are not idle either. Bharat Biotech and Serum Institute of India have initiated RSV research programs and are likely to bank on their experience in the production of pediatric and maternal vaccines. Tie-ups with global firms can also open the way for local production of monoclonal antibodies, leading to costs savings as well as wider availability. Experts put wide availability of RSV vaccines and antibodies in India at least 2 to 4 years down the road. Early access could start in corporate or private hospitals dealing with high-risk pregnancies. In the private sector, however, the incorporation of RSV prevention in the national immunization program will be crucial to making RSV vaccines and antibodies accessible and beneficial for all Indian infants—irrespective of birthplace. Article courtesy: Dr. Shreya Dubey - Consultant - Neonatology & Paediatrics, CK Birla Hospital, Gurugram Russia's Lavrov Sounds Alarm Over German Army Buildup Plan; 'Very Worrying, Need To…' One step to a healthier you—join Times Health+ Yoga and feel the change
Time of India
2 hours ago
- Time of India
Indian astronaut Shukla Axiom-4 mission set for June 10 lift-off, dock at ISS after 28-hour flight
Indian astronaut Shubhanshu Shukla and three others are set to embark on the Axiom Space 's fourth human spaceflight from NASA 's Kennedy Space Centre in Florida on June 10 and are likely to dock at the International Space Station on June 11 at about 10 PM IST, after a nearly 28-hour journey. Shukla, the mission pilot of the Axiom-4 (Ax4) commercial mission to the ISS, will be accompanied by mission commander Peggy Whitson and specialists Tibor Kapu from Hungary and Slawosz Uznanski-Wisniewski from Poland. The Axiom-4 mission will mark India's return to space 41 years after Rakesh Sharma's historic spaceflight onboard Russia's Soyuz mission in 1984. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What Happens When You Massage Baking Soda Into Your Scalp Read More Undo "The crew will travel to the orbiting laboratory on a new SpaceX Dragon spacecraft after launching on the company's Falcon 9 rocket. The targeted docking time is approximately 12:30 (10:00 p.m. IST), Wednesday, June 11," NASA said in a statement. ISRO Chairman V Narayanan visited Axiom Space last week to review the preparations for the spaceflight. Live Events The astronauts have been in quarantine since May 25 to prepare for the trip and have been training ahead of the launch on June 10. Discover the stories of your interest Blockchain 5 Stories Cyber-safety 7 Stories Fintech 9 Stories E-comm 9 Stories ML 8 Stories Edtech 6 Stories "The #Ax4 crew undergoes extensive emergency training, featuring a range of scenarios such as underwater escape drills," Axiom Space said in a post on X, and shared a video of the training programme. During the 14-day stay at the ISS, the Ax-4 crew is expected to interact with Prime Minister Narendra Modi, school students, and space industry leaders among others. Earlier this week, the crew addressed a press conference to give an update on the training ahead of the launch. "We are good for the launch, we have completed all the training and the team has bonded well," Whitson said on Tuesday. Shukla described the year-long training for the spaceflight as "nothing short of transformative". "It has been an amazing journey so far, but the best is yet to come. As I go into space, I carry not just instruments and equipment, I carry hopes and dreams of a billion hearts," Shukla said. Shukla is set to conduct exclusive food and nutrition-related experiments developed under a collaboration between the Indian Space Research Organisation (ISRO) and the Department of Biotechnology (DBT), with support from NASA. The experiments aim to pioneer space nutrition and self-sustaining life support systems vital for future long-duration space travel. ISRO has lined up a set of seven experiments for Shukla, who will also participate in five joint studies planned by NASA for its human research program. It has drawn up plans to focus on India-centric food for carrying out experiments on the ISS, including sprouting methi (Fenugreek) and moong (green gram) in microgravity conditions. Shukla will also expose the seeds to the macrobiotic conditions and bring them back to earth where they will be cultivated into plants not just once but over generations. Shukla's experience on the Axiom Mission 4 would be very well utilised on the Gaganyaan mission which is planned for 2027. ISRO is spending Rs 550 crore on the Axiom-4 mission. PTI
&w=3840&q=100)
Business Standard
6 hours ago
- Business Standard
Mukesh Ambani offers ₹151 cr 'Guru Dakshina' to honour ICT mentor
Ambani reminisced how the first lecture he attended at UDCT by Professor Sharma motivated him and how Sharma later played the role of quiet architect of India's economic reforms Press Trust of India New Delhi Reliance Industries Ltd chairman and managing director Mukesh Ambani announced an unconditional grant of Rs 151 crore to his alma mater the Institute of Chemical Technology, Mumbai. Ambani had graduated from ICT in the 1970s. He spent over three hours on Friday at ICT which back then was called the University Department of Chemical Technology (UDCT) at a function to publish Professor MM Sharma's biography 'Divine Scientist'. Ambani reminisced how the first lecture he attended at UDCT by Professor Sharma motivated him and how Sharma later played the role of quiet architect of India's economic reforms. Sharma impressed upon the policymakers that the only way for India to grow was to unshackle Indian industry from license-permit-raj, which would allow Indian players to build scale, reduce dependence on imports and compete globally. "Like my father Dhirubhai Ambani, he had a burning desire to change Indian industry from scarcity to global leadership," said Ambani, adding that "these two bold visionaries believed that science and technology, in alliance with private entrepreneurship, would open the floodgates of prosperity". Crediting the rise of the Indian chemical industry to Sharma's efforts, Ambani, in his speech, referred to him as 'a Rashtra Guru - a Guru of Bharat'. While speaking of 'Guru Dakshina', Ambani announced the unconditional grant of Rs 151 crore to ICT according to the instructions of Sharma. "When he tells us something, we just listen. We don't think. He told me Mukesh you have to do something big for ICT, and I am very pleased to announce that for Prof Sharma," Ambani said while referring to the grant.
